Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
J Eur Acad Dermatol Venereol
; 34(1): e1-e3, 2020 Jan.
Article
in En
| MEDLINE
| ID: mdl-31374134
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Carcinoma, Squamous Cell
/
Epidermolysis Bullosa Dystrophica
/
Antibodies, Monoclonal, Humanized
/
Celecoxib
/
Cetuximab
/
Antineoplastic Agents, Immunological
/
Genes, Recessive
/
Anti-Inflammatory Agents
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2020
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom